Cantitate/Preț
Produs
Total produse
Vezi coșul
Molecular Determinants of Head and Neck Cancer de Barbara Burtness

Molecular Determinants of Head and Neck Cancer: Current Cancer Research

Editat de Barbara Burtness, Erica A. Golemis
en Limba Engleză Hardback – 8 apr 2014
This book will benefit researchers interested in better understanding the biology of squamous cell cancers of the head and neck (SCCHN), with the goals of designing therapies, identifying risk factors and investigating the molecular basis of the disease.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (2) 111270 lei  6-8 săpt.
  Springer International Publishing – 29 dec 2018 111270 lei  6-8 săpt.
  Springer – 3 sep 2016 116157 lei  6-8 săpt.
Hardback (2) 97439 lei  3-5 săpt. +4927 lei  7-13 zile
  Springer International Publishing – 13 aug 2018 97439 lei  3-5 săpt. +4927 lei  7-13 zile
  Springer – 8 apr 2014 160956 lei  3-5 săpt.

Din seria Current Cancer Research

  • 5% Targeted Therapy of Acute Myeloid Leukemia
    Preț: 113209 lei
  • 5% Lung Cancer: New Understandings and Therapies
    Preț: 72866 lei
  • 5% Protein Kinase C in Cancer Signaling and Therapy
    Preț: 142121 lei
  • 5% Gene-Based Therapies for Cancer
    Preț: 109408 lei
  • 5% Cell Cycle Deregulation in Cancer
    Preț: 108985 lei
  • 5% Chemical Carcinogenesis
    Preț: 148157 lei
  • 5% Molecular Determinants of Radiation Response
    Preț: 109480 lei
  • 5% Cancer Associated Viruses
    Preț: 144773 lei
  • 5% Caveolins in Cancer Pathogenesis, Prevention and Therapy
    Preț: 70697 lei
  • 5% Burkitt’s Lymphoma
    Preț: 109681 lei
  • 5% Autophagy and Cancer
    Preț: 109848 lei
  • 5% Advances in Tumor Immunology and Immunotherapy
    Preț: 111217 lei
  • 5% Targeting Autophagy in Cancer Therapy
    Preț: 71463 lei
  • 5% Asbestos and Mesothelioma
    Preț: 129722 lei
  • 5% Advances in Biology and Treatment of Glioblastoma
    Preț: 110064 lei
  • 5% Early Phase Cancer Immunotherapy
    Preț: 110395 lei
  • 5% D-type Cyclins and Cancer
    Preț: 71535 lei
  • 5% Microbiome and Cancer
    Preț: 117103 lei
  • 5% Targeted Therapies for Lung Cancer
    Preț: 90244 lei
  • 5% Engineering and Physical Approaches to Cancer
    Preț: 160847 lei
  • 5% Circulating Tumor Cells: Advances in Liquid Biopsy Technologies
    Preț: 143878 lei

Preț: 160956 lei

Preț vechi: 169427 lei
-5% Nou

Puncte Express: 2414
Preț estimativ în valută:
30813€ • 31707$ • 25974£

Carte disponibilă

Livrare economică 08-22 februarie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461488149
ISBN-10: 1461488141
Pagini: 372
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.68 kg
Ediția:2014
Editura: Springer
Colecția Springer
Seria Current Cancer Research

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

Chapter 1: Overview: The Pathobiology of Head and Neck Cancer

Chapter 2: Human papillomavirus (HPV)-positive head and neck cancer and the Wnt signaling pathway…..Theodoros Rampias and Amanda Psyrri

Chapter 3: EGFR Inhibitors as Therapeutic Agents in Head and Neck Cancer…..Hanqing Liu, Jennifer R. Cracchiolo, Tim N. Beck, Ilya G. Serebriiskii, and Erica A. Golemis

Chapter 4: The Role of HGF/c-MET in Head and Neck Squamous Cell Carcinoma…..Tanguy Y. Seiwert, Tim N. Beck and Ravi Salgia
Chapter 5: Insulin-like Growth Factor-1 Receptors in Head and Neck Cancer…..Steven A. Rosenzweig and Casey O. Holmes

Chapter 6: The PI3K Signaling Pathway in Head and Neck Squamous Cell Carcinoma……Jason D. Howard and Christine H. Chung

Chapter 7: Jak/STAT Signaling in HNC…..Bhavana S. Vangara and Jennifer R. Grandis

Chapter 8: TGFβ regulates EMT in head and neck cancer…..Jill M. Neiman and Xiao-Jing Wang

Chapter 9: p53 in Head and Neck Cancer…..Jong-Lyel Roh and Wayne M. Koch

Chapter 10: DNA damage proteins and response to therapy in head and neck cancer…..Ranee Mehra and Ilya G. Serebriiskii

Chapter 11: Hypoxia and radioresistance in head and neck cancer…..Peiwen Kuo and Quynh-Thu Le

Chapter 12: The Wnt -catenin Signaling Circuitry in Head and Neck Cancer…..Rogerio M. Castilho and J. Silvio Gutkind

Chapter 13: Sequencing HNC: Emergence of Notch Signaling……Curtis R. Pickering, Thomas J. Ow, Jeffrey N. Myers

Chapter 14: Gene Expression in HNC…..Michael F Ochs and Joseph A Califano

Chapter 15: Epidemiology of HPV in Head and Neck Cancer; variant strains, discrete protein function…..Camille C.R. Ragin, Jeffrey C. Liu

Chapter 16: Projections: Novel Therapies for HPV-Negative Cancers of the Head and Neck…..Barbara Burtness

Notă biografică

Barbara Burtness, M.D. is Associate Director for Clinical Research at the Fox Chase Cancer Center. She is also a co-leader of the Keystone Program in Head and Neck Cancer. As Chair of the Head and Neck Committee in the Eastern Cooperative Oncology Group and a member of the NCI Head and Neck Steering Committee, she helps shape the national agenda for research on all stages of head and neck cancer.
Erica Golemis, Ph.D. is the Deputy Chief Scientific Officer at the Fox Chase Cancer Center. She is also the Co-Leader of Developmental Therapeutics and Co-Leader of the Head and Neck Cancer Keystone at Fox Chase. Her research seeks to define the changes in cell signaling that occur as tumors spread by metastasis and develop resistance to drugs, with the ultimate goal of inhibiting these processes.

Textul de pe ultima copertă

Head and neck cancers, involving sites from the nasopharynx to the subglottic larynx, are frequently devastating cancers that afflict patients around the world. These cancers are frequently locally advanced prior to detection, and require multimodality therapy that is associated with high morbidity. As this book addresses this difficult disease, it accomplishes three main goals.
First, it introduces the etiology and subclasses of squamous cell carcinomas of the head and neck (SCCHNs), and how these factors affect prognosis. Although habitual exposures to tobacco, alcohol, and other agents have historically been the main causes of SCCHN, a rising proportion of oropharynx cancers arise from transforming human papillomavirus (HPV) infection. These two broad classes of SCCHN have significant differences in disease profile and response to treatment, as we discuss.
Second, it summarizes the current state of understanding of the genetic, epigenetic and protein expression changes associated with the various classes of SCCHN. In the past decade, disease pathogenesis of SCCHN has been appreciated to involve deregulation of multiple tumor pathways, including the receptor tyrosine kinases (RTKs) EGFR, ERBB2, ERBB3, c-MET, and IGF1R; transforming growth factor β (TGFβ); Notch; cytoplasmic signaling proteins including PTEN, PI3K, JAK/STAT, and Wnt-responsive β-catenin; mutation control systems, including p53 and the DNA damage repair (DDR) machinery; and hypoxic response. The specific understanding of the action of these proteins in SCCHN is presented here.
Finally, this book defines potential therapeutic targets for improved management of the disease in the future, discussing prospects for improved prediction of prognosis.

Caracteristici

Summarize the unique pathobiology of head and neck cancers
Addresses signaling pathways and individual proteins that are important in causing or supporting the aggressive nature of head and neck cancer
Covers high throughput studies addressing chromosomal, mutational, and transcriptional changes that characterize SCCHN

Recenzii

“The book is intended primarily for clinicians, fellows, interns, and trainees, but medical students who may be interested in head and neck cancer but face the challenge of updating themselves on the latest innovations may also find this book very useful. … this is an informative and authoritative book on the subject that includes experiences from clinicians and scientists working on head and neck cancer at some of the most renowned cancer centers in the world.” (Ravi Salgia, Doody's Book Reviews, March, 2019)